Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factorAnaïs Schavgoulidze, Jill Corre, Alexis Talbot et al.|Blood|2022Cited by 64
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical featuresTitouan Cazaubiel, Jill Corre, Xavier Leleu et al.|Blood|2022Cited by 30
Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patientsHortense Thomas, Sophie Julia, David Geneviève et al.|Journal of Medical Genetics|2024Cited by 7
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Éric Lippert, Lina Benajiba et al.|Leukemia|2025Cited by 1